Esophageal Cancer – Causes, Symptoms, and Treatments
Having Esophageal Cancer is a serious health condition and should be treated with care. It can be devastating to have this condition, but thankfully, there are ways to treat it and prevent it from getting worse.
Symptoms
Symptoms of esophageal cancer vary, but they can include difficulty swallowing and chest pain. These symptoms are caused by cancer blocking the flow of food and liquids from the throat to the stomach. In some cases, cancer can spread to other parts of the body.
Most people with esophageal cancer have difficulty swallowing food or liquids, especially large solid food pieces and semi-solid food. People with esophageal cancer can have problems eating meat, bread, and other foods that can get stuck in their throats. The condition is called dysphagia.
People with esophageal cancer may also experience vomiting blood or mucus, weight loss, or anemia. These symptoms are more common in people who are older or have a history of esophageal diseases. People who are obese or have a family history of esophageal cancer are at a higher risk of developing the disease.
Esophageal cancer can be diagnosed by a healthcare provider using a physical exam and endoscopy. A CT scan or PET scan may be performed to confirm the diagnosis. Other tests may be necessary to determine the extent of cancer. If cancer has spread, chemotherapy may be used.
There are two primary types of esophageal cancer: adenocarcinoma and squamous cell carcinoma. Adenocarcinoma is the most common type of esophageal cancer. It develops in glandular cells of the esophagus, usually in the lower part of the esophagus near the stomach. Squamous cell carcinoma occurs in cells lining the upper and middle esophagus. Squamous cell tumors are associated with smoking and heavy alcohol consumption.
Esophageal cancer is usually not curable, but early detection and treatment can increase the chance of surviving the disease. Treatments include surgery and chemotherapy. Surgery involves the removal of part of the esophagus, which is reconstructed with tissue from the stomach. Other treatments include photodynamic therapy, in which a special drug is injected into the tumor. A surgeon may also insert a stent to keep the esophagus open.
Other complications include bone metastases, which can cause pain and tenderness over the bones. An elevated calcium level in the blood can also cause weakness. Cancer can also spread to the lymph nodes near the esophagus.
Epidemiology
During the last fifty years, the epidemiology of esophageal cancer has changed dramatically in the Western world. The epidemic has caused a major public health problem. Understanding esophageal cancer epidemiology will help to clarify causes, target screening strategies, and improve outcomes.
The highest rates of esophageal cancer occur in Eastern and Central Asia, Southern Africa, and the Great Rift Valley. Among these regions, fewer than 15% of cases occur in people younger than 55. Among patients in these age groups, the mortality rate is similar to the age-adjusted mortality rate for the entire population. This disparity has decreased in recent years. However, esophageal cancer still poses a major public health concern.
Approximately 80% of esophageal cancers are squamous cell carcinomas. SCCs typically develop in columnar glandular cells in the esophagus. The incidence of squamous cell carcinomas has been decreasing in the United States, although there are some exceptions. Among adults in the United States, men are more likely to develop esophageal cancer than women.
Among men, the most common risk factor for developing esophageal cancer is tobacco. Among tobacco users, the longer the tobacco use, the more the risk. Smoking cigarettes, cigars, pipes, and other tobacco products, such as chewing tobacco, is a risk factor for esophageal cancer. Similarly, excessive alcohol consumption is a risk factor for esophageal adenocarcinoma. In addition, obesity increases the risk of esophageal cancer.
The incidence of esophageal adenocarcinoma has increased sharply over the last few decades. Among adults in the United States, esophageal adenocarcinoma incidence is higher in white men than in black men. In addition, men are more likely than women to develop esophageal adenocarcinoma.
Among blacks, the age-adjusted incidence rate is twice as high as in whites. The mortality rate is also twice as high for blacks. However, the mortality rate is declining in recent years. The age-adjusted mortality rate is in line with the world incidence rate. The mortality rate for esophageal cancer is similar for men and women.
In addition to tobacco use, the risk for esophageal adenocarcinoma also increases with obesity. There is also an association between esophagitis and esophageal cancer.
Treatment options
Despite the poor survival rate of patients with esophageal cancer, several treatments are available to help patients live longer and better. These treatments are based on the stage of cancer and the patient’s overall health.
In patients with early-stage cancer, surgery is usually considered the best treatment option. The esophagus is removed and reconstructed with tissue from the stomach. Surgical removal is often accompanied by chemotherapy. Chemotherapy drugs destroy cancer cells. In addition to surgery and chemotherapy, radiation may be used as well.
Some patients may require a feeding tube. This tube is a flexible plastic tube that is passed through the mouth and into the stomach. The tube can be used for nutrition, but may also be used to prevent cancer from spreading. It is important to discuss this with your doctor.
Treatments may also include targeted drug therapies that target specific aspects of cancer. Some of the most active agents include taxanes, anthracyclines, and fluoropyrimidines. These drugs tend to have fewer side effects than traditional chemotherapy.
Clinical trials are a promising way to discover new treatments for esophageal cancer. These trials test promising drugs that are not yet available to the general public. They can also help researchers find out if a drug will be approved by the FDA. These trials also give patients access to the latest treatments.
Treatment options for esophageal cancer may also include chemotherapy, radiation therapy, and immunotherapy. These treatments are used to destroy cancer cells and alleviate the symptoms of cancer. They may be used before or after surgery.
Treatment options for esophageal can also include endoscopic treatments, such as cryotherapy or radiofrequency ablation. These treatments freeze or heat cancer cells to destroy them. These procedures can help ease the symptoms of cancer and relieve pain.
In patients with metastatic esophageal cancer, treatment options include surgery, chemotherapy, and radiation therapy. These treatment options can also be combined with immunotherapy, which attacks cancer cells with the body’s immune system. The effectiveness of these treatments depends on the stage of cancer and the location of the cancer.
Survival rates
Among the top three causes of cancer deaths in many countries, esophageal cancer is one of the most common. This disease accounts for over 500,000 cancer deaths annually and is among the top three cancers in the United States. Approximately 1 in 132 men and 1 in 455 women will be diagnosed with esophageal cancer during their lifetime. Despite advances in treatments, the overall survival rate is very low.
Despite the prevalence of esophageal cancer, little information exists regarding survival rates at different anatomical locations. The goal of this study was to compare survival rates for EEC patients in three different regions and to evaluate the impact of the anatomical location and other factors on survival rates.
This study was performed on a population-based sample of patients diagnosed with EEC. Patients were analyzed for survival at three different locations: Western Asia, Eastern Asia, and South Africa. Despite the differences in geographic location, the survival rates for EEC in these three regions were similar. The overall survival rates for patients were months at one year and months for five years.
There are two major histological subtypes of esophageal cancer: adenocarcinoma and squamous cell carcinoma. The incidence of squamous cell carcinomas has increased in recent years in western populations. It is also believed that adenocarcinomas have a slightly better overall prognosis than squamous cell carcinomas.
Detailed information on the histological subtypes and risk factors for esophageal cancer is not currently available in most countries. However, a recent study has shown that esophageal cancer incidence is increasing in some countries, such as Thailand and the Czech Republic. It is expected that the incidence rate of esophageal cancer in these countries will continue to increase.
Despite the large number of studies based on data from high-income countries, little is known about esophageal cancer survival rates in countries with less developed economies. Therefore, it is important to obtain accurate information on survival rates for esophageal cancer patients in countries with high incidence rates.
Several prediction models have been developed for survival rates. However, it is important to refine the models before implementing them in clinical practice. The current study evaluated the effectiveness of these models.
Health Sources:
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/
